There has been much recent interest in the relationship between androgens a
nd bone mineralization in men. Increases in serum androgens during puberty
allow for skeletal maturation and the attainment of peak bone mass, and the
persistence of normal testosterone secretion during adulthood is important
for the maintenance of bone density. Testosterone deficiency is associated
with heightened bone turnover and is a major risk factor for osteoporosis
in men. The administration of testosterone to androgen-deficient men leads
to an increase in bone mass, particularly in the trabecular bone compartmen
t, and a reduction in levels of surrogate markers of bone turnover, suggest
ing that androgens have a dampening effect on bone remodelling. In addition
, the administration of androgens to eugonadal men with idiopathic osteopor
osis, with resulting supraphysiological testosterone concentrations, may le
ad to increases in bone mineral density. The risk of osteopenia due to andr
ogen deficiency and the benefits of testosterone substitution therapy or su
praphysiological administration on bone will be reviewed.